What drug is ritexitinib?

Ritlecitinib is a Januskinase3 (JAK 3) and tyrosine kinase inhibitor that acts on the immune system. Ritexitinibis used to treat severe alopecia areata (an autoimmune disease that causes patchy hair loss).

Before usingritixitinib Before, When deciding to use a drug, you must weigh the risks and benefits of taking it. Tell your doctor ifpatienthas any unusual or allergic reaction to this drug or any other drug. Also tellyour doctor if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For over-the-counter medicines, read the label or package ingredients carefully. The relationship between age and the efficacy of ritixitinib in children 12 years of age has not been appropriately studied. Safety and effectiveness have not been established. Appropriate studies conducted to date have not shown geriatric-specific issues that would limit the effectiveness of ritixitinib in older adults. However, elderly patients are more likely to experience adverse reactions (such as infections), which may require caution and dose adjustment in patients receivingritixitinib. There have not been adequate studies in women to determine the risk to the baby if this medication is used during breastfeeding. Before taking this medication while breastfeeding, weigh the potential benefits against the potential risks. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.